Lantheus Holdings Appoints New Chief Medical Officer
Ticker: LNTH · Form: 8-K · Filed: Jun 24, 2024 · CIK: 1521036
| Field | Detail |
|---|---|
| Company | Lantheus Holdings, Inc. (LNTH) |
| Form Type | 8-K |
| Filed Date | Jun 24, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $350,000, $900,000, $50,000, $450,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-change, leadership
TL;DR
Lantheus Holdings swaps CMOs: Dr. O'Malley steps up, Dr. Smith departs.
AI Summary
Lantheus Holdings, Inc. announced on June 17, 2024, the appointment of Dr. Brian D. O'Malley as Chief Medical Officer. Dr. O'Malley previously served as the company's Senior Vice President of Medical Affairs. The company also reported the departure of Dr. Robert E. Smith from his role as Chief Medical Officer, effective the same date. These changes are part of the company's ongoing leadership adjustments.
Why It Matters
Changes in key executive positions like the Chief Medical Officer can signal shifts in a company's strategic direction, particularly in areas like research and development or clinical trial oversight.
Risk Assessment
Risk Level: low — The filing details routine executive leadership changes without any indication of financial distress or significant operational disruption.
Key Players & Entities
- Lantheus Holdings, Inc. (company) — Registrant
- Dr. Brian D. O'Malley (person) — Appointed Chief Medical Officer
- Dr. Robert E. Smith (person) — Departed Chief Medical Officer
- June 17, 2024 (date) — Effective date of changes
FAQ
Who has been appointed as the new Chief Medical Officer of Lantheus Holdings, Inc.?
Dr. Brian D. O'Malley has been appointed as the new Chief Medical Officer of Lantheus Holdings, Inc.
When did the changes in the Chief Medical Officer role become effective?
The changes became effective on June 17, 2024.
Who previously held the position of Chief Medical Officer?
Dr. Robert E. Smith previously held the position of Chief Medical Officer.
What was Dr. O'Malley's prior role within Lantheus Holdings, Inc.?
Prior to his appointment as Chief Medical Officer, Dr. O'Malley served as the Senior Vice President of Medical Affairs for Lantheus Holdings, Inc.
What is the principal executive office address for Lantheus Holdings, Inc.?
The principal executive office address is 201 Burlington Road, South Building, Bedford, Massachusetts 01730.
Filing Stats: 821 words · 3 min read · ~3 pages · Grade level 11.8 · Accepted 2024-06-24 17:00:58
Key Financial Figures
- $0.01 — ich registered Common stock, par value $0.01 per share LNTH The Nasdaq Global Ma
- $350,000 — etter"). Her annual base salary will be $350,000, and she will be eligible for a discret
- $900,000 — h an aggregate grant date fair value of $900,000, which awards will be granted on or abo
- $50,000 — e. The Offer Letter also provides for a $50,000 sign-on bonus. Pursuant to her Offer
- $450,000 — ncentive awards, with a target value of $450,000. There are no arrangements or underst
Filing Documents
- d826874d8k.htm (8-K) — 23KB
- 0001193125-24-167026.txt ( ) — 143KB
- lnth-20240617.xsd (EX-101.SCH) — 3KB
- lnth-20240617_lab.xml (EX-101.LAB) — 18KB
- lnth-20240617_pre.xml (EX-101.PRE) — 11KB
- d826874d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LANTHEUS HOLDINGS, INC. By: /s/ Daniel M. Niedzwiecki Name: Daniel M. Niedzwiecki Title: Chief Administrative Officer, General Counsel and Corporate Secretary Date: June 24, 2024